Skip to main content
. Author manuscript; available in PMC: 2018 Jun 11.
Published in final edited form as: J Drugs Dermatol. 2016 Aug 1;15(8):988–994.

Figure 1.

Figure 1

Differentially expressed skin genes and GO pathways after adalimumab treatment identified by RNAseq. A) Log 2 fold change of top 25 differentially expressed genes in the skin is listed. B) GO pathway term, p-value, false discovery rate (FDR) identified by DAVID enrichment analysis based on gene list.